Symbiotec Pharmalab Launches Rs 1,757 Crore IPO with Price Band Rs 938-988
Symbiotec Pharmalab, a Madhya Pradesh-based pharmaceutical and biotechnology company, is launching a Rs 1,757 crore IPO from August 24 to 27, 2026. The issue includes a Rs 150 crore fresh equity component and a Rs 1,607 crore offer for sale by existing shareholders. The price band is set between Rs 938 and Rs 988 per share, valuing the company around Rs 6,350 crore. Shares will be listed on BSE and NSE on September 1, with allotment expected by August 28. The IPO reserves 50% for institutional buyers, 15% for non-institutional investors, and 35% for retail investors.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 42/100.
Outlets measured: news18, economictimes, mint, moneycontrol. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
moneycontrol broke this story on 19 Aug, 03:25 am. Other outlets followed.